BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 38374016)

  • 1. Multivariate logistic regression analysis of the clinical factors influencing locally advanced prostate cancer.
    Ke Z; Xu Y; Shu Y; Wang C; Wu B; Zhang B; Xiang P; Hu X
    Transl Cancer Res; 2024 Feb; 13(2):676-685. PubMed ID: 38482405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data.
    Yamada Y; Naruse K; Nakamura K; Taki T; Tobiume M; Zennami K; Nishikawa G; Itoh Y; Muramatsu Y; Nanaura H; Nishimura M; Takii K; Adham AO; Honda N
    Exp Ther Med; 2010 Jul; 1(4):635-639. PubMed ID: 22993586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of risk factors for bone metastasis in newly diagnosed prostate cancer patients.
    Peng C; Juan C; Mao W; Jinghe Y; Renli T
    Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3832-3839. PubMed ID: 35731052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical association between coagulation indexes, platelet-related parameters, and bone metastasis of newly diagnosed prostate cancer.
    Yu Z; Yuan M; Chen G
    Eur J Med Res; 2023 Dec; 28(1):587. PubMed ID: 38093347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M; Cheki M; Salehi-Marzijarani M; Amuchastegui T; Gholamrezanezhad A
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):286-9. PubMed ID: 23478119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Can the tumor stage of prostate carcinoma be determined with the aid of prostate-specific antigen?].
    Semjonow A; Hertle L
    Urologe A; 1995 Jul; 34(4):290-6. PubMed ID: 7545843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Factors Influencing Bone Metastasis in Prostate Cancer and Diagnostic Value of Serum PSA, CysC and D-D.
    Liu X; Zhao C; Lin J; Liu B
    Arch Esp Urol; 2024 Jan; 77(1):72-78. PubMed ID: 38374016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment level of serum sialic acid predicts both qualitative and quantitative bone metastases of prostate cancer.
    Sun J; Tian T; Wang N; Jing X; Qiu L; Cui H; Liu Z; Liu J; Yan L; Li D
    Front Endocrinol (Lausanne); 2024; 15():1338420. PubMed ID: 38384968
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.